Opens in a new tab

Meril v Edwards Lifesciences (CoA, 18 April 2025)

Date18 April 2025
CourtCoA
DivisionLuxembourg (LU)
Type of actionApplication Rop 223
Registry referenceApp_9095/2025 · ORD_10080/2025
PartiesMeril Gmbh, Meril Life Sciences Pvt Ltd. v. Edwards Lifesciences Corporation

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 18 April 2025 (UPC_CoA_166/2025), the Court of Appeal rejects the application by Meril GmbH and Meril Life Sciences for suspensive effect of their appeal against the Munich Local Division’s decision of 15 November 2024, as rectified on 17 February 2025, finding infringement of Edwards Lifesciences’ EP 3 646 825, or alternatively for a stay of enforcement against security. The order confirms that enforceability pending appeal is the rule and that arguments going to the merits of the appeal do not establish a manifest error.

Question

Should an appeal against an infringement decision have suspensive effect, or enforcement be stayed against security, where the appellant alleges errors of claim construction, a breach of the right to be heard and a pending appeal on validity?

Decision

An appeal has no suspensive effect save in exceptional circumstances, such as a manifestly erroneous decision or an appeal that would otherwise become devoid of purpose (paragraph 13). The appeal is not devoid of purpose, since Edwards undertook not to publish the decision (paragraph 14), claim construction and the other grounds are for the appeal on the merits (paragraph 15). A pending appeal on revocation is not enough on its own (paragraph 22). The alternative request, based on Rules 223.1 and 352.1, lacks a proper legal basis and runs against the rule that decisions are enforceable pending appeal (paragraphs 27 and 28). Costs are not decided (paragraph 30).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 74(1)
Rules of Procedure
Rules 118.2(a), 118.8, 223.1 and 352.1
Case law cited
Court of Appeal, 19 June 2024, ICPillar v ARM (UPC_CoA_301/2024), Court of Appeal, 29 October 2024, Belkin v Philips (UPC_CoA_549/2024).

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: UPC Court of Appeal.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Application Rop 223
Outcome (Dhenne Avocats summary)
La cour d’appel refuse l’effet suspensif à l’appel de Meril contre la décision de contrefaçon de la division locale de Munich et rejette la demande subsidiaire de suspension de l’exécution contre garantie, faute de base juridique.
Appeal
Decision of the Court of Appeal.
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 646 825
A system comprising a prosthetic valve and a delivery catheter
recorded proprietor: Edwards Lifesciences Corp
Mentioned in the analysis (role not qualified)
Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.